Skip to main content
. 2021 Jun 22;9(9):3308–3320.e3. doi: 10.1016/j.jaip.2021.06.010

Figure 1.

Figure 1

Patients who were skin tested owing to symptoms after mRNA COVID-19 vaccination that were concerning for an allergic reaction. (A) All patients. (B) Patients with immediate allergic reactions. (C) Patients with delayed allergic reactions. ∗Three patients who had positive skin testing to both polyethylene glycol (PEG) and polysorbate are represented in the PEG category only for the purpose of illustration. †One patient did not receive the next dose in the series and instead received Janssen. ‡Two patients had grade 0 reactions and 1 had a grade 1 reaction. §Three patients had a grade 0 reaction, 9 had a grade 1 reaction, and 3 had a grade 2 reaction. ‖Two patients who had positive skin testing to both PEG and polysorbate are represented in the PEG category only for the purpose of illustration. ¶One patient did not receive the next dose in the series and instead received Janssen. #One patient had a grade 0 reaction and 1 had a grade 1 reaction. ∗∗Two patients had a grade 0 reaction, 8 patients had a grade 1 reaction, and 3 had a grade 2 reaction. ††One patient who had positive skin testing to both PEG and polysorbate is represented in the PEG category only for the purpose of illustration. ‡‡One patient had a grade 0 reaction. §§One patient had a grade 0 reaction and 1 had a grade 1 reaction.